prikaz prve stranice dokumenta The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis
  Download
PDF 783.78 KB
Scientific paper - Review paper
The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis
Medicina, 60 (2024), 3; 477. https://doi.org/10.3390/medicina60030477
Kirigin Biloš, Lora Stanka; Altabas, Velimir; Vukić Dugac, Andrea; Baretić, Maja

Institutional repository: Dr Med - University of Zagreb School of Medicine Digital Repository

Cite this document

Kirigin Biloš, L. S., Altabas, V., Vukić Dugac, A. & Baretić, M. (2024). The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis. Medicina, 60. (3). doi: 10.3390/medicina60030477

Kirigin Biloš, Lora Stanka, et al. "The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis." Medicina, vol. 60, no. 3, 2024. https://doi.org/10.3390/medicina60030477

Kirigin Biloš, Lora Stanka, Velimir Altabas, Andrea Vukić Dugac and Maja Baretić. "The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis." Medicina 60, no. 3 (2024). https://doi.org/10.3390/medicina60030477

Kirigin Biloš, L. S., et al. (2024) 'The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis', Medicina, 60(3). doi: 10.3390/medicina60030477

Kirigin Biloš LS, Altabas V, Vukić Dugac A, Baretić M. The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis. Medicina [Internet]. 2024 March 14 [cited 2024 December 28];60(3). doi: 10.3390/medicina60030477

L. S. Kirigin Biloš, V. Altabas, A. Vukić Dugac and M. Baretić, "The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis", Medicina, vol. 60, no. 3, March 2024. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:761419. [Accessed: 28 December 2024]

Metadata
Title (english)The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis
AuthorLora Stanka Kirigin Biloš
AuthorVelimir Altabas
AuthorAndrea Vukić Dugac
AuthorMaja Baretić
Author's institutionUniversity of Zagreb
School of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract (english)
Cystic fibrosis-related diabetes (CFRD) is the most common comorbidity in patients with cystic fibrosis (CF). CFRD has been correlated with important clinical outcomes, including poor nutrition, reduced pulmonary function, and earlier mortality. However, clinical decline due to abnormalities of blood glucose (dysglycemia) begins early in CF, before the diagnosis of CFRD by the gold-standard oral glucose tolerance test (OGTT). Continuous glucose monitoring (CGM) has been validated in patients with CF and has been recognized as a valuable tool in detecting early glucose abnormalities in patients with CF. Several CGM parameters have been used to predict CFRD in some but not all studies, and there is no consensus regarding CGM use for diagnostic purposes. Thus, it remains a complementary test to OGTT in CFRD diagnosis. The aim of this review is to provide an update on the pathophysiological mechanisms of CFRD, recent advances in the use of CGM for CFRD screening, and the association between CGM measures and CF-related clinical outcomes.
Keywords (english)
Languageenglish
Publication typeScientific paper - Review paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleMedicina
Numberingvol. 60, no. 3, 477
e-ISSN1648-9144
DOIhttps://doi.org/10.3390/medicina60030477
URN:NBNurn:nbn:hr:105:761419
Publication2024-03-14
Document URLhttps://www.mdpi.com/1648-9144/60/3/477
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution 4.0 International (CC BY 4.0) icon
Created on2024-09-30 08:08:34